Related Experiment Videos
Expression and a role of CD30 in regulation of T-cell activity
1Department of Immunotoxicology, Nofer's Institute of Occupational Medicine, Loxz, Poland. maciekt@imp.lodz.pl
Abstract:
CD30 receptor has been known for almost 20 years, but its expression and activity are still the subject of many investigations. Its expression was found in different malignancies, and most of the studies regarding CD30 focus on its role in lymphomas. The progress that has already been made in this field is reflected in implementation of CD30 as a target for immunotoxin, which has been tested in phase I study in treating Hodgkin lymphoma. CD30 is present also on normal, activated T cells of all cytokine profiles. However, increased density of CD30 and CD30-mediated Th2 cytokine production provide evidence of its role in determining the activity of T cells toward synthesis of cytokines and involvement in reactions of Th2 characteristics. Pleiotropic signaling mediated by CD30 does not implicate this receptor just as a cytokine costimulator; it proves to be important in several different activities of T cells.
Insights
The CD30 receptor, crucial in lymphomas and T cell activity, is being investigated for its role in malignancies and Th2 immune responses. Its signaling impacts various T cell functions beyond costimulation.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- The CD30 receptor is well-established but its precise expression and function remain under investigation.
- CD30 is notably expressed in various malignancies, particularly lymphomas, and on normal activated T cells.
- Current research includes targeting CD30 for immunotoxin therapy in Hodgkin lymphoma.
Purpose of the Study:
- To explore the multifaceted roles of the CD30 receptor.
- To investigate CD30 expression and activity in both malignant and normal T cells.
- To understand CD30's contribution to T cell cytokine production and immune responses.
Main Methods:
- Review of existing literature on CD30 expression and function.
- Analysis of studies focusing on CD30 in lymphomas and T cell activation.
- Examination of CD30-mediated signaling pathways and cytokine production.
Main Results:
- CD30 expression is confirmed in diverse malignancies and on activated T cells.
- Increased CD30 density correlates with Th2 cytokine production.
- CD30 signaling influences T cell activity and Th2-type reactions.
Conclusions:
- The CD30 receptor plays a significant role in T cell-mediated immune responses, particularly Th2 pathways.
- CD30's function extends beyond cytokine costimulation, impacting various T cell activities.
- Further research into CD30 signaling may reveal new therapeutic strategies for immune-related diseases and cancers.